Nagata Y, Ishigaki T, Okajima K, Fujiwara K, Kinashi T, Mitumori M, Ooya N, Kitakabu Y, Hiraoka M, Abe M
Department of Radiology, Kyoto University Hospital, Japan.
Cardiovasc Intervent Radiol. 1993 Jan-Feb;16(1):14-8; discussion 18-20. doi: 10.1007/BF02603031.
Two or three sessions of transcatheter arterial infusion (TAI) therapy were performed preoperatively in 13 patients with advanced cervical cancer (stage 3 or more). The efficacy of TAI was evaluated by tumor markers, magnetic resonance imaging (MRI), and postoperative histopathological examination. In all cases, tumor marker levels decreased after TAI therapy, and MRI also showed a decrease in the tumor size in 11/12 patients. The tumor tissue resected at radical hysterectomy showed no viable cancer cells in 6 patients, and no viable extrauterine cancer was detected in 5 more patients. Thus, TAI performed via both internal iliac arteries reduced both tumor size and extension to the parametrium, and it appears to have the potential to be an effective treatment modality for advanced cervical cancer.
对13例晚期宫颈癌(3期及以上)患者在术前进行了两到三次经导管动脉灌注(TAI)治疗。通过肿瘤标志物、磁共振成像(MRI)和术后组织病理学检查评估TAI的疗效。在所有病例中,TAI治疗后肿瘤标志物水平下降,并且MRI显示12例患者中有11例肿瘤大小减小。在根治性子宫切除术中切除的肿瘤组织在6例患者中未发现存活癌细胞,另有5例患者未检测到子宫外存活癌。因此,通过双侧髂内动脉进行的TAI可减小肿瘤大小并减少向子宫旁组织的浸润,似乎有可能成为晚期宫颈癌的一种有效治疗方式。